全文获取类型
收费全文 | 6257篇 |
免费 | 639篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 106篇 |
儿科学 | 150篇 |
妇产科学 | 69篇 |
基础医学 | 753篇 |
口腔科学 | 176篇 |
临床医学 | 649篇 |
内科学 | 1232篇 |
皮肤病学 | 98篇 |
神经病学 | 552篇 |
特种医学 | 353篇 |
外科学 | 755篇 |
综合类 | 229篇 |
一般理论 | 2篇 |
预防医学 | 695篇 |
眼科学 | 93篇 |
药学 | 513篇 |
1篇 | |
中国医学 | 5篇 |
肿瘤学 | 474篇 |
出版年
2021年 | 81篇 |
2020年 | 64篇 |
2019年 | 94篇 |
2018年 | 114篇 |
2017年 | 79篇 |
2016年 | 87篇 |
2015年 | 118篇 |
2014年 | 139篇 |
2013年 | 227篇 |
2012年 | 282篇 |
2011年 | 298篇 |
2010年 | 187篇 |
2009年 | 186篇 |
2008年 | 280篇 |
2007年 | 244篇 |
2006年 | 269篇 |
2005年 | 223篇 |
2004年 | 217篇 |
2003年 | 230篇 |
2002年 | 201篇 |
2001年 | 177篇 |
2000年 | 177篇 |
1999年 | 163篇 |
1998年 | 96篇 |
1997年 | 100篇 |
1996年 | 100篇 |
1995年 | 85篇 |
1994年 | 81篇 |
1993年 | 96篇 |
1992年 | 185篇 |
1991年 | 159篇 |
1990年 | 134篇 |
1989年 | 153篇 |
1988年 | 138篇 |
1987年 | 116篇 |
1986年 | 95篇 |
1985年 | 105篇 |
1984年 | 62篇 |
1983年 | 59篇 |
1982年 | 53篇 |
1981年 | 52篇 |
1979年 | 48篇 |
1978年 | 50篇 |
1976年 | 59篇 |
1975年 | 64篇 |
1974年 | 53篇 |
1973年 | 55篇 |
1972年 | 68篇 |
1971年 | 53篇 |
1970年 | 50篇 |
排序方式: 共有6905条查询结果,搜索用时 0 毫秒
61.
Since its discovery, human parvovirus B19 has been linked with a broad spectrum of clinical syndromes. An aetiological role for the virus has been confirmed in erythema infectiosum, transient aplastic crisis, persistent infection manifesting as pure red cell aplasia in immunocompromised persons, non-immune hydrops fetalis and arthritis. Less commonly recognised, but receiving increasing attention recently, are the neurological manifestations, a variety of which have been described in patients with either clinically diagnosed or laboratory confirmed B19 infection. The purpose of this review is to summarise present knowledge of B19, its known and potential pathogenic mechanisms and its association with human diseases, particularly those with neurological manifestations. The outcome of the review supports an aetiological role of the virus in neurological disease. However, the pathogenesis remains unknown and elucidating this is a priority. 相似文献
62.
Baclofen reduced the frequency and aborted the bursts of spontaneous paroxysmal discharges in rat neocortical slices maintained in magnesium-free medium. This action was prevented by pretreatment with barium or caesium, which each increased the ictaform burst frequency, amplitude and duration. 4-Amino-pyridine also increased the burst frequency but reduced the amplitude and did not completely prevent the action of baclofen. Evidently baclofen suppresses such discharges by opening potassium channels normally involved in limiting the burst activity. 相似文献
63.
Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency. 总被引:3,自引:0,他引:3 下载免费PDF全文
EDTA plasma from patients with hereditary angioedema (HAE), the genetic deficiency of C1-inhibitor, when incubated at 37 degrees produces a kinin-like activity which can induce contraction of oestrus rat uterus. The second component of complement (C2) has previously been suggested to be the source of this kinin-like activity, with the implication that C2-kinin is a normal product of complement activation. Our results show that purified human C2 is cleaved rapidly to C2a and C2b when added to HAE plasma, but not normal plasma or plasma from a danazol-treated HAE patient. However, the addition to HAE plasma of C2 at 20 X normal plasma concentration had no effect on the kinin activity generated on incubation at 37 degrees. In the presence of soya bean trypsin inhibitor, the rate of C2 cleavage and products were unaltered but no kinin activity was generated. C2 was cleaved by purified C1s to C2a and C2b. Incubation of C2 with trypsin resulted in cleavage to C2a and C2b followed by more extensive cleavage of both C2a and C2b. Kallikrein cleaved C2 to C2a and C2b but plasmin had no effect on C2. In no case was kinin activity generated. When C2 was cleaved by C1s to C2a and C2b then incubated with trypsin, kallikrein, or plasmin, no kinin activity was generated: only trypsin cleaved the C2 fragments further. The results suggest that C2 is not the source of the kinin-like activity generated in hereditary angioedema plasma. 相似文献
64.
Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro 总被引:10,自引:0,他引:10
Dopamine and glutamate are key neurotransmitters involved in learning and memory mechanisms of the brain. These two neurotransmitter systems converge on nerve cells in the neostriatum. Dopamine modulation of activity-dependent plasticity at glutamatergic corticostriatal synapses has been proposed as a cellular mechanism for learning in the neostriatum. The present research investigated the role of specific subtypes of dopamine receptors in long-term potentiation (LTP) in the corticostriatal pathway, using intracellular recording from striatal neurons in a corticostriatal slice preparation. In agreement with previous reports, LTP could be induced reliably under Mg(2+)-free conditions. This Mg(2+)-free LTP was blocked by dopamine depletion and by the dopamine D-1/D-5 receptor antagonist SCH 23390 but was not blocked by the dopamine D-2 receptor antagonist remoxipride or the GABA(A) antagonist picrotoxin. In dopamine-depleted slices, the ability to induce LTP could be restored by bath application of the dopamine D-1/D-5 receptor agonist, SKF 38393. These results show that activation of dopamine D-1/D-5 receptors by either endogenous dopamine or exogenous dopamine agonists is a requirement for the induction of LTP in the corticostriatal pathway. These findings have significance for current understanding of learning and memory mechanisms of the neostriatum and for theoretical understanding of the mechanism of action of drugs used in the treatment of psychotic illnesses and Parkinson's disease. 相似文献
65.
J. S. Kerr A. Ciuffetelli Jr. H. D. Hall T. M. Stevens N. R. Ackerman W. M. Mackin 《Inflammation research》1987,21(3-4):293-296
Intratracheal administration of PMA produces acute lung injury in part due to the generation of O2-derived free radicals. This study evaluated the role of the antioxidant enzyme superoxide dismutase (SOD) in PMA-induced lung injury in the rat. PMA was instilled into rats intratracheally (20–60 g/kg), and the lungs were lavaged 4 hr later. Total number of cells recovered from lavage after PMA treatment was not different from the total number recovered from controls; lavagable PMNs increased in a dose-dependent manner. Albumin in lavage fluid (an index of lung vascular permeability) was significantly increased at 60 g/kg PMA. SOD (10,000 U)+PMA (60 g/kg) reduced the albumin level but significantly increased both total number of cells and number of PMNs recovered from lavage fluid. To investigate the possibility that SOD decreases the ability of PMNs to adhere, PMN aggregation was measuredin vitro. The results indicated that 10,000 U SOD can inhibit PMA-induced aggregation by 50%. In contrast, aggregation to other stimuli (e.g., fMet-Leu-Phe, A23187) was unaffected by SOD. We conclude SOD prevents PMA-induced lung permeability and diminishes PMN adherence. 相似文献
66.
W. L. Kerr R. J. Baskin Y. Yeh 《Pflügers Archiv : European journal of physiology》1990,416(6):679-688
Microstructural features of relaxed, skinned muscle fibers compressed with polyvinylpyrollidone were examined by optical diffraction ellipsometry. This technique is sensitive to the optical anisotropy within the muscle, including that due to intrinsic properties of the protein molecules as well as that due to the regular arrangement of proteins in the surrounding medium. The change in polarization state of light after interacting with the muscle is described by the differential field ratio (DFR) and birefringence (n). Compression of single fibers (sarcomere length = 2.6 m) with 0%–21% polyvinylpyrrolidone caused an increase of up to 23% and 31% for DFR and n, respectively. The largest increase in both parameters occurred at intermediate sarcomere lengths. Theoretical modelling of the results suggest that the average S-1 tilt angle may be reduced upon compression of the filament lattice. This is supported by experiments in which S-1 was enzymatically cleaved with -chymotrypsin. Separate experiments comparing fibers with intact membranes and skinned fibers compressed to an equivalent lattice spacing showed little difference in DFR or n. 相似文献
67.
Identification of two mutations in a compound heterozygous child with dihydrolipoamide dehydrogenase deficiency 总被引:1,自引:0,他引:1
Hong YS; Kerr DS; Craigen WJ; Tan J; Pan Y; Lusk M; Patel MS 《Human molecular genetics》1996,5(12):1925-1930
An infant girl with elevated blood lactate, pyruvate, and plasma
branched-chain amino acids was diagnosed with dihydrolipoamide
dehydrogenase (E3; dihydrolipoamide: NAD+ oxidoreductase, EC 1.8.1.4)
deficiency. Activities of the pyruvate dehydrogenase complex and E3 from
patient were 26 and 2% of controls in blood lymphocytes, and 11 and 14% in
cultured skin fibroblasts, respectively. Western blot analysis demonstrated
that the amount of E3 protein in fibroblasts from the patient and her
father was about half of controls, while Northern blot analysis showed
normal amounts of E3 RNA. DNA sequencing of cloned full-length E3 cDNAs
from the patient revealed two mutations in separate alleles. One is a
single base insertion of an extra adenine in the last codon of the leader
peptide sequence (TAC-->TAAC) leading to a nonsense mutation which
results in the premature termination of the precursor E3 polypeptide
(Y35X). The other is a missense mutation due to substitution of guanine for
adenine, causing an Arg-->Gly substitution at amino acid 460 of the
mature protein (R460G) which triggers the loss of E3 activity probably by
structural change in the E3 dimer. DNA sequencing of E3 cDNAs from the
parents demonstrated that the nonsense mutation was inherited from the
father and the missense mutation was inherited from the mother.
相似文献
68.
The E2 glycoprotein of the alphavirus Ross River virus (RRV) contains three defined neutralization epitopes (a, b1 and b2) with determinants located between amino acids 216 and 251 in the linear sequence (Vrati et al., 1988, Virology 162, 346-353). The antigenic structure of this region has been examined using hyperimmune mouse antiserum against RRV and antiserum against four synthetic peptides representing linear amino acid sequences in the neutralization region of E2. In plaque reduction neutralization tests using hyperimmune antiserum to RRV, an RRV mutant altered at all three neutralization epitopes was markedly more resistant than the parental virus; variants altered at single epitopes could not be distinguished in these tests. Sera from mice immunized with synthetic RRV E2 peptides conjugated to keyhole limpet haemocyanin reacted, in a direct ELISA, with the specific region of RRV represented by the peptide. The same sera did not neutralize or immunoprecipitate RRV in solution or bind to RRV in a capture ELISA. The RRV peptides did not prime mice to react to a subimmunogenic dose of RRV; they did not bind monoclonal or polyclonal antibodies to RRV. We conclude that a significant proportion of the neutralizing antibody response in mice is elicited by epitopes a, b1, and b2 of RRV E2 and that the sites to which neutralizing antibodies bind are formed by complex folding. 相似文献
69.
Kerr K 《The Hastings Center report》1985,15(3):6-7
Kerr, a reporter whose Newsday team won a Pulitzer Prize in 1984 for coverage of the Baby Jane Doe story, briefly summarizes public and congressional reaction to the Department of Health and Human Services' proposed rule on the care of handicapped infants. A letter from the six Senators who had constructed the compromise legislation implementing the rule appears to have been particularly influential in the final wording of the regulation. Kerr concludes that, whatever happens next, the medical care of newborns has entered the political arena and will not easily be removed. 相似文献
70.
Gerald Batist Raymond W. Klecker Jr. Hiremagalur N. Jayaram Jean F. Jenkins John Grygiel Daniel C. Ihde Joyce L. Eddy Robert L. Fine Ian G. Kerr Jerry M. Collins 《Investigational new drugs》1985,3(4):349-355
Summary Tiazofurin (2--D-ribofuranosylthiazole-4-carboxamide, TCAR) is a synthetic C-nucleoside that demonstrated significant in vivo activity against a variety of animal tumors as well as in vitro activity against human tumor-derived cell lines. Thirteen patients were treated with TCAR administered as a 5-day continuous infusion in this Phase I trial. Seventeen complete cycles were administered in three dose levels ranging from 550 to 1450 mg/M2. Dose-limiting toxicities were myelosuppression and neurotoxicity including severe lethargy. Other toxicities including superficial skin peeling, myalgias, and tearing were seen at all doses. One patient had chest pain on day 4 resulting in stopping the drug, however, there was no evidence of cardiac or pericardial disease. Uric acid levels rose within one day in the absence of allopurinol treatment. There were no treatment related deaths. HPLC measurement of drug levels demonstrated steady-state plasma levels during the infusion, and a half-life following the infusion of 7.7 ± 0.6 hours. Minor abnormalities in renal function were associated with dramatic changes in pharmacokinetics and toxicity. No clinical responses were observed in this trial.Abbreviations TCAR
Tiazofurin
- HPLC
High performance liquid chromatography
- IMPD
Inosine monophosphate dehydrogenase
- WBC
white blood cell
- CPK
creatine phosphokinase
- Css
steady-state concentration 相似文献